Results 161 to 170 of about 8,760 (227)

Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson's Disease. [PDF]

Magn Reson Med Sci
Fujiwara Y, Sakae N, Kumazoe H, Miyamoto K, Hirakawa Y, Kan H, Yamashita K, Kitajima M.   +7 more
europepmc   +1 more source

Current Neuroimaging Modalities to Distinguish Parkinson's Disease from its Mimics: Imaging Features and Implications for Clinical Practice. [PDF]

Neuroradiol J
Gad M, Deng F, Prasuhn J, Luna LP.
europepmc   +1 more source

GABA outperforms iron and neuromelanin in detecting nigrostriatal alterations in early-stage Parkinson's disease with RBD. [PDF]

NPJ Parkinsons Dis
Zhang Y, Huang P, Liu P, Li Y, Jin Z, Yu Q, Shi X, Liu Y, Cheng Z, Wu P, Weng J, Liu F, Haacke EM, Cui Y, Chen S, He N, Yan F.   +16 more
europepmc   +1 more source

Characterisation of localised pigment accumulation in brains of eastern grey kangaroos (Macropus giganteus) after clinical disease due to chronic Phalaris species toxicosis. [PDF]

Aust Vet J
El-Hage C, Chen T, Tatarczuch L, Hufschmid J, Skerratt LF, Whiteley P, Davis N, Ploeg R.   +7 more
europepmc   +1 more source

Neuromelanin-Sensitive MRI Contrast and Chronic Depression in Young Women.

JAMA Netw Open
Perlman G, Kotov R, Wengler K, Moeller SJ, Horga G, Abi-Dargham A, Klein DN.   +6 more
europepmc   +1 more source

Biomarkers and neuroimaging markers in Parkinson's disease. [PDF]

Chin Med J (Engl)
Su D, Zheng Y, Feng T.
europepmc   +1 more source

Ferroptosis inhibition protects against α-synuclein-related neuronal cell death. [PDF]

Cell Death Dis
Majerníková N, Caiado MJ, Seinstra RI, Couzijn S, Goya ME, Salinas CS, Truong H, van der Sluis T, Miedema A, van Kempen LCLT, McColl G, Nollen EAA, Dolga AM, den Dunnen WFA.   +13 more
europepmc   +1 more source